Tap into a variety of videos and downloadable resources to help you learn about and prescribe POTELIGEO
See how POTELIGEO works
Videos illustrate the unique mechanism of action of POTELIGEO, POTELLIGENT® technology, the role of C-C chemokine receptor type 4,1 and key points of the infusion process.
POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.
Important Safety Information
SEE MORE
This website is intended for healthcare providers in the US
You are about to leave this site and be redirected to another website. Do you wish to continue?
Want to stay informed?
We will send you the latest updates about POTELIGEO® (mogamulizumab-kpkc), as well as helpful information for you, your staff, and your patients.